The Problem:

There is a Lack of Access to Quality Care

About Us

We are people with Parkinson’s dedicated to elevating the voices of those with lived experience of Parkinson’s to inform the way Parkinson’s is understood, treated, and ultimately cured.

What We Offer

Resolve Parkinson’s offers opportunities for you to contribute to a changed future. You can help us transform the future of Parkinson’s.

One of the most critical obstacles in the fight against Parkinson’s disease is the lack of access to quality Parkinson’s-specific care in the U.S. Despite advancements in research and treatment, many patients continue to face significant disparities in receiving the care they need, contributing to preventable suffering and missed opportunities for improved quality of life.

Limited Access to Neurological Expertise

Neurologists play a vital role in managing Parkinson’s disease, yet patients often experience limited and prescriptive interactions. In many cases:

  • Neurology appointments last only 30 minutes, twice a year.
  • Patients report that neurologists often focus on monitoring decline and adjusting prescriptions, rather than exploring comprehensive care strategies.
  • Neurologists frequently lack resources to offer effective, holistic treatments.

 

Why This Matters

Data shows that people newly diagnosed with Parkinson’s who see a neurologist are:

  • 20% less likely to die within six years.
  • 20% less likely to require placement in a nursing home.

 

Furthermore, referrals to allied specialists such as physical therapists or dieticians often lead to frustration, as many lack specific training in Parkinson’s care. Non-pharmaceutical interventions — like exercise, vitamin B1, and light therapy — are often overlooked due to insufficient research or liability concerns, leaving patients to navigate alternative treatments alone.

The Facts: Disparities in Access to Care

Research underscores alarming disparities in Parkinson’s care access:

  • 14% of patients receive no care at all.
  • 29% rely on primary care providers who may lack specialized knowledge.
  • Only 9% receive care from movement disorder specialists, the gold standard of Parkinson’s care.
  • Care gaps are especially stark for women, people of color, and those in rural areas, who face heightened challenges in receiving timely diagnoses and appropriate treatment.
  • Mental health support is another glaring gap, with 53% of Medicare beneficiaries with Parkinson’s suffering from depression, but only 2% receiving mental health treatment.

Data shows that people newly diagnosed with Parkinson's who see a neurologist are 20% less likely to die within six years and 20% less likely to require placement in a nursing home.

The Importance of a Multidiscipinary Approach to Care

Effective treatment for Parkinson’s requires a team-based approach. A Parkinson’s Foundation Center of Excellence exemplifies this standard, bringing together:

  • Neurologists and movement disorder specialists with advanced training
  • Physical, occupational, and speech therapists
  • Mental health professionals and nutritionists.

These centers offer up-to-date medications, therapies, and access to clinical trials. However, with only 34 Centers of Excellence in the U.S. for over 1 million patients and 48 globally for 11 million patients, access remains critically limited.

Steps Towards a Solution

Resolve Parkinson’s is dedicated to bridging these gaps. By advocating for improved access to specialized care and supporting the establishment of more Centers of Excellence, we aim to ensure every person living with Parkinson’s can receive the comprehensive, multidisciplinary care they deserve.

The Problems We See

The System of Care is Poorly Designed

The current system to assist people with Parkinson’s appears to have evolved without rational planning. Systemic issues include lack of patient access to Parkinson’s specific care, ineffective drug therapies, and a poorly socialized standard of care in health settings. This has led many patients to try to manage their care on their own.

The Definition of Parkinson’s is Too Narrow

Parkinson’s is a multisystemic syndrome rather than solely a movement disorder limited to brain neurology. A focus on non-motor symptoms is critical to understanding how Parkinson’s evolves and how early intervention may slow or halt the disease.

Alternative Therapies are Excluded from Research

Led by desperation and ineffective drug therapies, patients with Parkinson’s have found relief through lifestyle changes and treatments that aren’t patentable or otherwise able to be monetized. These approaches have been eschewed by the mainstream medical community.

The Patient Voice is Being Ignored

Parkinson’s patients need to have a seat at the table throughout the clinical research process. Patient input into how resources are used is a critical missing element that will bring about change if broadly applied. Positioning the patient voice more powerfully will disrupt stagnation and drive change.

Research Targets Are Profit-Driven

The pharmaceutical industry ecosystem dictates where research funding is allocated. Patients with Parkinson’s need to be positioned as leaders in the fight to improve care and find a cure. Their voice needs to be a critical component of legislation and research targets.

Researchers Ask the Wrong Questions

There is a dearth of creative thinking in the Parkinson’s field. Research priorities need to shift to include the investigation of a broader range of hypotheses concerning Parkinson’s origin and progression. Out-of-the-box thinking can spur innovation that may lead to a breakthrough towards better treatment and a cure.
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.